Enriched environments in stroke rehabilitation - Eventbrite

This should be totally unnecessay since a protocol should have been written up and distributed worldwide from this in 2011. But baby steps to get stroke rehab to some semblance of mediocracy.

This enriched environment talked about by Dr. Dale Corbett in 2011?

 

Enriched environments in stroke rehabilitation - Eventbrite

Date and Time

Sat 1 December 2018
09:30 – 15:30 GMT

Add to Calendar

Location

Basement Lecture Theatre
The Clinical Neuroscience Centre
33 Queen Square
London
WC1N 3BG
United Kingdom
View Map

Description

London ACPIN are delighted to present a fantastic study day with Heidi Janssen, exploring environmental enrichment (EE) in acquired brain injury.

Heidi Janssen is a Physiotherapist and Researcher at the Hunter Medical Research Institute, Newcastle, NSW, Australia.

Heidi will be speaking about about the theory of enriched environments, animal models, evidence base, in community and inpatient environments. Click HERE for link to article

This study day aims to;

Provide evidence in animal models of acquired brain injury regarding the anatomical, molecular and behavioural effects of exposure to enriched environments.

Outline the main hypotheses concerning the underlying mechanisms of effect

Discuss barriers and enablers to activity and implementing enriched environments from both perspective of patient with ABI and staff, based on delegates’ experiences and research findings.

Present published evidence for the use of enriched environments with people recovering from or living with an ABI: in the Acute, Sub-acute and Chronic stages

09:00 registration for 9:30 start

Access to and delivery of acute ischaemic stroke treatments: A survey of national scientific societies and stroke experts in 44 European countries

This should have been totally unnecessary because the president of that great stroke association is already receiving continuously updated reports from every stroke hospital and country showing how well they are following stroke protocols and the results they are obtaining. This is business 101. Does no one in the stroke medical world know how to run and improve a business?

Access to and delivery of acute ischaemic stroke treatments: A survey of national scientific societies and stroke experts in 44 European countries 

Show all authors

Diana Aguiar de Sousa*, Rascha von Martial*, Sònia Abilleira, ...

First Published July 20, 2018 Research Article

https://doi.org/10.1177/2396987318786023

Article information

Abstract

Introduction

Acute stroke unit care, intravenous thrombolysis and endovascular treatment significantly improve the outcome for patients with ischaemic stroke, but data on access and delivery throughout Europe are lacking. We assessed best available data on access and delivery of acute stroke unit care, intravenous thrombolysis and endovascular treatment throughout Europe.

Methods

A survey, drafted by stroke professionals (ESO, ESMINT, EAN) and a patient organisation (SAFE), was sent to national stroke societies and experts in 51 European countries (World Health Organization definition) requesting experts to provide national data on stroke unit, intravenous thrombolysis and endovascular treatment rates. We compared both pooled and individual national data per one million inhabitants and per 1000 annual incident ischaemic strokes with highest country rates. Population estimates were based on United Nations data, stroke incidences on the Global Burden of Disease Report.

Results

We obtained data from 44 European countries. The estimated mean number of stroke units was 2.9 per million inhabitants (95% CI 2.3–3.6) and 1.5 per 1000 annual incident strokes (95% CI 1.1–1.9), highest country rates were 9.2 and 5.8. Intravenous thrombolysis was provided in 42/44 countries. The estimated mean annual number of intravenous thrombolysis was 142.0 per million inhabitants (95% CI 107.4–176.7) and 72.7 per 1000 annual incident strokes (95% CI 54.2–91.2), highest country rates were 412.2 and 205.5. Endovascular treatment was provided in 40/44 countries. The estimated mean annual number of endovascular treatments was 37.1 per million inhabitants (95% CI 26.7–47.5) and 19.3 per 1000 annual incident strokes (95% CI 13.5–25.1), highest country rates were 111.5 and 55.9. Overall, 7.3% of incident ischaemic stroke patients received intravenous thrombolysis (95% CI 5.4–9.1) and 1.9% received endovascular treatment (95% CI 1.3–2.5), highest country rates were 20.6% and 5.6%.

Conclusion

We observed major inequalities in acute stroke treatment between and within 44 European countries. Our data will assist decision makers implementing tailored stroke care programmes for reducing stroke-related morbidity and mortality in Europe.

Revisited: A Systematic Review of Therapeutic Hypothermia for Adult Patients Following Traumatic Brain Injury

Well no real benefit so you don't have to start wondering who in stroke will DO NOTHING.  This review should have been totally unnecessary since the last team to research hypothermia should have updated the protocol and public database on this.
https://journals.lww.com/ccmjournal/Abstract/onlinefirst/Revisited___A_Systematic_Review_of_Therapeutic.96295.aspx

Watson, Hannah, I.¹; Shepherd, Andrew, A.¹; Rhodes, Jonathan K., J.^1,2; Andrews, Peter J., D.³

Critical Care Medicine: March 29, 2018 - Volume Online First - Issue - p

doi: 10.1097/CCM.0000000000003125

Neurologic Critical Care: PDF Only

• Abstract
• Author Information

Objectives: Therapeutic hypothermia has been of topical interest for many years and with the publication of two international, multicenter randomized controlled trials, the evidence base now needs updating. The aim of this systematic review of randomized controlled trials is to assess the efficacy of therapeutic hypothermia in adult traumatic brain injury focusing on mortality, poor outcomes, and new pneumonia.

Data Sources: The following databases were searched from January 1, 2011, to January 26, 2018: Cochrane Central Register of Controlled Trial, MEDLINE, PubMed, and EMBASE.

Study Selection: Only foreign articles published in the English language were included. Only articles that were randomized controlled trials investigating adult traumatic brain injury sustained following an acute, closed head injury were included. Two authors independently assessed at each stage.

Data Extraction: Quality was assessed using the Cochrane Collaboration’s tool for assessing the risk of bias. All extracted data were combined using the Mantel-Haenszel estimator for pooled risk ratio with 95% CIs. p value of less than 0.05 was considered statistically significant. All statistical analyses were conducted using RevMan 5 (Cochrane Collaboration, Version 5.3, Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014).

Data Synthesis: Twenty-two studies with 2,346 patients are included. Randomized controlled trials with a low risk of bias show significantly more mortality in the therapeutic hypothermia group (risk ratio, 1.37; 95% CI, 1.04–1.79; p = 0.02), whereas randomized controlled trials with a high risk of bias show the opposite with a higher mortality in the control group (risk ratio, 0.70; 95% CI, 0.60–0.82; p < 0.00001).

Conclusions: Overall, this review is in-keeping with the conclusions published by the most recent randomized controlled trials. High-quality studies show no significant difference in mortality, poor outcomes, or new pneumonia. In addition, this review shows a place for fever control in the management of traumatic brain injury.